BioNTech SE - ADR vs Wolfspeed Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.78B), while Wolfspeed Inc trades at $35.19 (market cap $1.75B). The key difference: BioNTech SE - ADR is far larger — about 13× Wolfspeed Inc's market cap, and Wolfspeed Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | WOLF | |
|---|---|---|
Market Cap | $22.78B | $1.75B |
Sector | Health | Technology |
52-Week High | $119.34 | $73.68 |
52-Week Low | $83.89 | $1.19 |
Enterprise Value | $6.45B | $2.41B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →